By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte Corporation 

Maxygen, Inc. 

Intergen Company 

Company News
Analysts Predict FDA Approval Of Novo Nordisk A/S (NVO)'s Obesity Drug By Year-End 10/21/2014 5:51:12 AM
Jacobs Engineering Group Inc. Receives Pharmaceuticals Pilot Plant Contract From Novo Nordisk A/S (NVO) 9/30/2014 10:03:20 AM
Novo Nordisk A/S (NVO) To Create 60 Jobs At New Seattle Obesity Center 9/26/2014 6:08:05 AM
Novo Nordisk A/S (NVO) Supports National Hemophilia Foundation Initiative For "Collaborating In Care" Disease Management Program 9/18/2014 10:07:18 AM
Novo Nordisk A/S (NVO)'s Diabetes Drug Ryzodeg Effective In Phase 3b Study 9/18/2014 6:23:09 AM
Novo Nordisk A/S (NVO) May Add Hundreds To R&D Staff For Obesity Medicines 9/17/2014 6:51:50 AM
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children 9/16/2014 6:05:24 AM
Novo Nordisk A/S (NVO)'s Liraglutide Safe, Effective For Obesity: FDA Panel 9/12/2014 6:02:28 AM
FDA Initial Briefs Find Novo Nordisk A/S (NVO)'s Liraglutide Effective 9/10/2014 6:33:22 AM
Orexigen Therapeutics, Inc. (OREX), Novo Nordisk A/S (NVO) Seek To Enter Still Struggling Obesity Market This Week 9/9/2014 6:44:20 AM